PLANETS
4.2.2020 03:02:07 CET | Business Wire | Press release
teamLab Planets TOKYO is a museum in Toyosu, Tokyo where you walk through water and can immerse yourself in massive artworks barefoot. In the first year since teamLab Planets TOKYO opened in July of 2018, there have been more than 1.25 million visitors from 106 countries and regions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200203005275/en/
At teamLab Planets TOKYO, two artworks in the museum will be transformed by cherry blossoms for a limited time from March 1 to April 30, 2020.
Also, with the opening of the Toyosu Fish Market and Edomae Jokamachi nearby, you can enjoy food made using fresh ingredients, collect Japanese Culture souvenirs, and enjoy local shopping.
- Cherry Blossoms Transform Two Artworks
In the work Floating in the Falling Universe of Flowers , flowers bloom and change with every passing minute, creating a universe of life that spreads across the space. For a limited time only, cherry blossoms fall in the art space.
In another artwork, Drawing on the Water Surface Created by the Dance of Koi and People - Infinity , visitors walk barefoot through real water, as koi swim across the infinite water's surface. When the koi collide with people, they bloom into cherry blossoms. The flowers that bloom change in real time according to the seasonal changes of the year.
Check the teamLab Planets website for more details: https://planets.teamlab.art/
teamLab Planets highlight video: https://youtu.be/cqiv_FV8iT4
- Become Bodily Immersed in a Massive Art Space
teamLab Planets is a museum where you walk through water. It consists of 4 vast exhibition spaces with 7 distinct artworks. The artworks are based on art collective teamLab’s concept of “Body Immersive.”
By immersing the entire body with other people in these massive “Body Immersive” artworks, the boundary between the body and the artwork dissolves, the boundaries between the self, others, and the world become something continuous, and we explore a new relationship without boundaries between ourselves and the world.
Visitors enter the museum barefoot, and become completely immersed with other visitors in the vast artwork spaces.
- Artworks Transformed by Cherry Blossoms
Floating in the Falling Universe of Flowers
teamLab, 2016-2018, Interactive Digital Installation, Endless, Sound: Hideaki Takahashi
Artwork: https://planets.teamlab.art/tokyo/ew/fitfuof/
Video: https://youtu.be/FzJ5svgIueQ
A seasonal year of flowers bloom and change with time, life spreads out into the universe.
Lie down or sit still in the space and eventually your body floats and you dissolve into the artwork world.
The artwork is rendered in real time by a computer. I is neither prerecorded nor on loop. Interaction between the viewer and the installation causes continuous change in the artwork.
Flowers grow, bud, bloom, and in time, the petals fall, and the flowers wither and die. The cycle of birth and death continues for perpetuity.
The universe at this moment in time can never be seen again.
Drawing on the Water Surface Created by the Dance of Koi and People - Infinity
teamLab, 2016-2018, Interactive Digital Installation, Endless, Sound: Hideaki Takahashi
Artwork: https://planets.teamlab.art/tokyo/ew/koi_and_people/
Video: https://youtu.be/SsRNptTOniw
Koi swim on the surface of water that stretches out into infinity. People can walk into the water.
The movement of the koi is influenced by the presence of people in the water and also other koi. When the fish collide with people they turn into flowers and scatter. Throughout a year, the flowers that bloom will change along with the seasons.
The trajectory of the koi is determined by the presence of people and these trajectories trace lines on the surface of the water.
The work is rendered in real time by a computer program. It is neither prerecorded nor on loop. The interaction between the viewer and the installation causes continuous change in the artwork. Previous visual states can never be replicated, and will never reoccur.
- Museum overview
teamLab Planets TOKYO
Address: teamLab Planets TOKYO, Toyosu 6-1-16, Koto-ku, Tokyo
Hours: Monday - Thursday 10:00 - 19:00
Friday 10:00 - 21:00
Saturday and the day before holidays 9:00 - 21:00
Sunday and Holidays 9:00 - 19:00
* Last entry 30 minutes before closing.
* Special hours Friday, March 20 - Saturday, April 4: 9:00 - 21:00
* Special hours Sunday, April 5: 9:00 - 19:00
Closed:
Thursday, February 13, 2020
Thursday, March 12, 2020
Monday, April 6, 2020
Tuesday, April 14, 2020
Wednesday, April 15,2020
Admission:
Adults (18 years and older) JPY 3,200
University students / Specialized students JPY 2,500
Junior high school students / High school students JPY 2,000
Children (Ages 4-12) JPY 800
Seniors (65 years and older) JPY 2,400
Disability discount JPY 1,600
teamLab Planets website: https://planets.teamlab.art/
teamLab Planets TOKYO Ticket Store: https://teamlabplanets.dmm.com
* Prices and opening hours are subject to change. Please check the official website before visiting.
- Social Networking Sites:
Instagram: https://www.instagram.com/teamlab.planets/
Facebook: https://www.facebook.com/TL.Planets/
Twitter: https://twitter.com/teamLabPlanets
#teamLabPlanets
- Jointly Managed Food Stand
Everything is in your hand
- Hours -
Monday - Thursday 10:00 - 18:00
Friday 10:00 - 20:00
Saturday and the day before holidays 10:00 - 20:00
Sunday and Holidays 10:00 - 18:00
- Closed -
Same as teamLab Planets
* Establishment may be closed in cases of extreme weather.
Check here for more information: https://planets.teamlab.art/tokyo/foodstand
PLANETS Co., Ltd.
The managing entity for facilities operations at teamLab Planets TOKYO and the associated restaurants.
Address: Tokyo Nihonbashi Tower 26F, 2-7-1 Nihonbashi, Chuo-ku, Tokyo
Representative: Takumi Nomoto
teamLab
teamLab (f. 2001) is an international art collective, an interdisciplinary group of various specialists such as artists, programmers, engineers, CG animators, mathematicians and architects whose collaborative practice seeks to navigate the confluence of art, science, technology, and the natural world.
teamLab aims to explore the relationship between the self and the world and new perceptions through art. In order to understand the world around them, people separate it into independent entities with perceived boundaries between them. teamLab seeks to transcend these boundaries in our perception of the world, of the relationship between the self and the world, and of the continuity of time. Everything exists in a long, fragile yet miraculous, borderless continuity of life.
teamLab has been the subject of numerous exhibitions at venues worldwide, including New York, London, Paris, Singapore, Silicon Valley, Beijing, Taipei, and Melbourne among others. The permanent museums teamLab Borderless opened in Odaiba, Tokyo in June 2018, and teamLab Borderless Shanghai in Huangpu District, Shanghai on November 5, 2019. The massive body immersive space teamLab Planets in Toyosu, Tokyo is on view until Fall 2020. The latest permanent museum teamLab SuperNature in Macao to launch in March, 2020.
teamLab’s works are in the permanent collection of the Art Gallery of New South Wales, Sydney; Art Gallery of South Australia, Adelaide; Asian Art Museum, San Francisco; Asia Society Museum, New York; Borusan Contemporary Art Collection, Istanbul; National Gallery of Victoria, Melbourne; and Amos Rex, Helsinki.
teamLab is represented by Pace Gallery .
teamLab: https://www.teamlab.art/
Instagram: https://instagram.com/teamlab/
facebook: https://www.facebook.com/teamLab.inc
twitter: https://twitter.com/teamLab_net
YouTube: https://www.youtube.com/c/teamLabART
View source version on businesswire.com: https://www.businesswire.com/news/home/20200203005275/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
